Lung cancer is one of the commonest malignant neoplasms all over the world. It accounts for more cancer deaths than any other cancer. It is increasingly being recognized in India. We did a systematic review of the published studies on epidemiology, diagnosis and treatment of lung cancer in Ind...
Financial constraints faced by the families play a vital role in cancer treatment refusal, non-adherence, and failure of the prescribed therapy. This revie... A Natarajan,T Rajkumar,N Mehra - 《Medical Oncology》 被引量: 0发表: 2020年 Unmet Needs of Oral Cancer Survivors in India: A Perspe...
In India, lung cancer constitutes 6.9% of all new cancer cases and 9.3% of all cancer cases. There has also been a dramatic rise worldwide in both the absolute and relative frequencies of lung cancer occurrence. In 1953 it became the most common cause of cancer mortality in men. By 1985...
be a fatal one. Among all types of cancer present, this one is said to be responsible for maximum number of deaths all over the world. Fortunately, there is present treatment to cure this ailment. But this needs to be done by thebest cancer specialist in Indiaand during the earlier ...
(COPD), cystic fibrosis, pulmonary fibrosis, pulmonary hypertension, or bronchiectasis. A lung transplant can also be a treatment option for some people with lung cancer, sarcoidosis, or congenital lung defects. However, the transplant is a complex and risky operation that requires a ...
As lung cancer is a disease that may be asymptomatic in early stages, patients often present with advanced disease, where conventional treatment alone may not result in effective eradication of the cancer. Fortunately, thanks to advances in lung cancer treatment over t...
To kill the curiosity in me, I googled cost of generic Tarceva in India. This is what I get. In many countries, the brand-name Tarceva 150 mg drug costs about $18,700to 19,000 (price subject to vary) per 30 tablets. However, the mass production of generic cancer drugs versions ...
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage[J] . Yngvar Nilssen,......
Lung cancer is the prime cause of cancer-related deaths globally, with a contribution of 85% from non-small cell lung cancer. Before a few decades back, conventional chemotherapy was the most chosen treatment option for NSCLC but with side effects. Now, the treatment approaches have shifted to...
Reddy has released its generic version of Erlotinib for non-small cell lung cancer. At the same time, Cipla has widened its scope with the introduction of Nivolumab, which is also an immunotherapy drug. These players are capitalizing on cheap manufacturing costs in India to meet the treatment ...